ADAR1 Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

ADAR1 Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,000	Closed	-$3.17M	–	298
2023 Q4	$3.17M	Buy	+10,000	New	+$1.94M	1.13%	19

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

ADAR1 Capital Management's KRTX Position: Q1 2024 in Review

ADAR1 Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 10,000 shares — an estimated $3.17M sold.

ADAR1 Capital Management first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $3.17M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

ADAR1 Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
ADAR1 Capital Management sold 10,000 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.17M.
ADAR1 Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
ADAR1 Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $3.17M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on ADAR1 Capital Management's 13F filing for Q1 2024, filed 15 May 2024.